Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vaidehi Nafade
Observed name:
Nafade, Vaidehi
Institutions:
Research Institute of the McGill University Health Centre,
McGill University
Observed institutions:
Montreal Neurological Institute and Hospital,
Research Institute of the McGill University Health Centre,
McGill University
ORCID:
0009-0001-9521-5949
Observed ORCID:
0009-0001-9521-5949
OpenAlex ID:
A5070510886
Antibiotic prescription practices in primary care in low- and middle-income countries: A systematic review and meta-analysis
2020
·
Giorgia Sulis
, Pierrick Adam
, et al.
·
PLoS Medicine
·
353
PDF
A bibliometric analysis of tuberculosis research, 2007–2016
2018
·
Vaidehi Nafade
, Madlen Nash
, et al.
·
PLoS ONE
·
118
PDF
Global health journals need to address equity, diversity and inclusion
2019
·
Vaidehi Nafade
, Paulami Sen
, et al.
·
BMJ Global Health
·
89
PDF
Current progress towards prevention of Nipah and Hendra disease in humans: A scoping review of vaccine and monoclonal antibody candidates being evaluated in clinical trials
2024
·
Valerie Rodrigue
, Katie Gravagna
, et al.
·
Tropical Medicine & International Health
·
53
Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism
2019
·
Imane Frouni
, Adjia Hamadjida
, et al.
·
Neuropharmacology
·
47
Tuberculosis case fatality in India: a systematic review and meta-analysis
2020
·
Sophie Huddart
, Anita Svadzian
, et al.
·
BMJ Global Health
·
45
PDF
Over-the-counter antibiotic dispensing by pharmacies: a standardised patient study in Udupi district, India
2019
·
Vaidehi Nafade
, Sophie Huddart
, et al.
·
BMJ Global Health
·
45
PDF
Finding the missing millions: lessons from 10 active case finding interventions in high tuberculosis burden countries
2020
·
Tripti Pande
, Nathaly Aguilera Vasquez
, et al.
·
BMJ Global Health
·
33
PDF
The highly selective mGlu 2 receptor positive allosteric modulator LY‐487,379 alleviates l ‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson's disease
2020
·
Adjia Hamadjida
, Lamia Sid‐Otmane
, et al.
·
European Journal of Neuroscience
·
26
The value of diagnostic imaging for enhancing primary care in low- and middle-income countries
2024
·
Vaidehi Nafade
, Paulami Sen
, et al.
·
EClinicalMedicine
·
13
Objective cough counting in clinical practice and public health: a scoping review
2025
·
Alexandra J Zimmer
, Rishav Das
, et al.
·
The Lancet Digital Health
·
10
Tuberculosis: a Persistent Health Challenge for India
2018
·
Sophie Huddart
, Vaidehi Nafade
, et al.
·
Current Epidemiology Reports
·
7
Vaccine Candidates Designed to Prevent Enterotoxigenic Escherichia coli Diarrhoea: A Scoping Review of Clinical Trials Evaluating Vaccine Candidates in Development
2026
·
Vaidehi Nafade
, Naheemot O. Sule
, et al.
·
Tropical Medicine & International Health
·
2
PDF
Author response for "The highly‐selective mGlu 2 receptor positive allosteric modulator, LY‐487,379 alleviates L‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson’s disease"
2019
·
Adjia Hamadjida
, Lamia Sid‐Otmane
, et al.
·
Publons reviews and discussion
·
1
Sensitivity of Tuberculosis Infection Diagnostic Tests Among Different Populations: A Systematic Review and Meta-analysis
2026
·
Namrata Rana
, Raphaëlle Noseworthy
, et al.
·
Open Forum Infectious Diseases
Global Landscape of Vaccination Policies for the Use of Recombinant Zoster Vaccine (RZV) to Prevent Herpes Zoster (Shingles)
2026
·
Katie Gravagna
, Yang Zhang
, et al.
·
Current Epidemiology Reports
Author response for "The highly‐selective mGlu 2 receptor positive allosteric modulator, LY‐487,379 alleviates L‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson’s disease"
2020
·
Adjia Hamadjida
, Lamia Sid‐Otmane
, et al.
·
Publons reviews and discussion
Show more works
View as search
Works count:
19
Citation count:
842
H-index:
10
I10-index:
11
Year
Topic
Type